ANGIOTENSIN-II TYPE 1A RECEPTOR-DEFICIENT MICE WITH HYPOTENSION AND HYPERRENINEMIA

被引:335
|
作者
SUGAYA, T
NISHIMATSU, SI
TANIMOTO, K
TAKIMOTO, E
YAMAGISHI, T
IMAMURA, K
GOTO, S
IMAIZUMI, K
HISADA, Y
OTSUKA, A
UCHIDA, H
SUGIURA, M
FUKUTA, K
FUKAMIZU, A
MURAKAMI, K
机构
[1] UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN
[2] UNIV TSUKUBA,TSUKUBA ADV RES ALLIANCE,TSUKUBA,IBARAKI 305,JAPAN
[3] NATL INST ANIM HLTH,TSUKUBA,IBARAKI 305,JAPAN
[4] TANABE SEIYAKU CO LTD,LEAD GENERAT RES LABS,KASHIMA,OSAKA 532,JAPAN
关键词
D O I
10.1074/jbc.270.32.18719
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin (AT) II, the bioactive octapeptide in the renin-angiotensin system that plays a key role in cardiovascular homeostasis, exerts its multiple effects through the different types of AT receptors, AT1a, AT1b, and AT2. Previously, we showed chronic hypotension in angiotensinogen (the precursor of AT)-deficient mice and a dramatic increase in renin mRNA levels in its kidney, but it remains unclear which types of AT receptors regulate the blood pressure and renin gene expression, In order to elucidate the physiological roles of AT1a receptor, we generated mutant mice with a targeted replace ment of the AT1a receptor loci by the lacZ gene, In the heterozygous mutant mice, the strong lacZ staining was found in the glomerulus and juxtaglomerular apparatus of the renal cortex, which coincided with that of the signals detected by in situ hybridization, Chronic hypotension was observed in the heterozygous and homozygous mutant mice, with 10 and 22 mm Mg lower systolic blood pressure, respectively, than that of wild-type littermates. Both the levels of renin mRNA in the kidney and plasma renin activity were markedly increased only in the homozygous mutant mice, These results demonstrated that an AT1a-mediated signal transduction pathway is, at least in part, involved in the regulation of blood pressure and renin gene expression.
引用
收藏
页码:18719 / 18722
页数:4
相关论文
共 50 条
  • [1] Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice
    Satoh, M
    Kashihara, N
    Yamasaki, Y
    Maruyama, K
    Okamoto, K
    Maeshima, Y
    Sugiyama, H
    Sugaya, T
    Murakami, K
    Makino, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (02): : 317 - 325
  • [2] Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice
    Kurosaka, Maya
    Suzuki, Tatsunori
    Hosono, Kanako
    Kamata, Yuji
    Fukamizu, Akiyoshi
    Kitasato, Hidero
    Fujita, Yoshikuni
    Majima, Masataka
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (09) : 627 - 634
  • [3] Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice
    Ichihara, Atsuhiro
    Suzuki, Fumiaki
    Nakagawa, Tsutomu
    Kaneshiro, Yuki
    Takemitsu, Tomoko
    Sakoda, Mariyo
    Nabi, A. H. M. Nurun
    Nishiyama, Akira
    Sugaya, Takeshi
    Hayashi, Matsuhiko
    Inagami, Tadashi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07): : 1950 - 1961
  • [4] Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice
    Bek, MJ
    Wang, XY
    Asico, LD
    Jones, JE
    Zheng, SP
    Li, XX
    Eisner, GM
    Grandy, DK
    Carey, RM
    Soares-da-Silva, P
    Jose, PA
    HYPERTENSION, 2006, 47 (02) : 288 - 295
  • [5] Suppression of glomerular and renal hypertrophy in diabetes induced in angiotensin II type 1a receptor-deficient mice.
    Okamoto, K
    Kashihara, N
    Sugiyama, H
    Sekikawa, T
    Maeshima, Y
    Kanao, K
    Sato, M
    Maruyama, K
    Makino, H
    Sugaya, T
    Hisada, Y
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3150 - A3150
  • [6] Angiotensin II type 1A receptor-deficient mice are protected against angiotensin II-mediated glomerular injury and cardiac hypertrophy.
    Maruyama, K
    Kashihara, N
    Sugiyama, H
    Okamoto, K
    Kanao, K
    Maeshima, Y
    Satoh, M
    Sekikawa, T
    Makino, H
    Sugaya, T
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1439 - A1439
  • [7] Renal interstitial fibrosis with unilateral ureteral obstruction is reduced in angiotensin II type 1a receptor-deficient mice.
    Satoh, M
    Kashihara, N
    Sugiyama, H
    Okamoto, K
    Kanao, K
    Maeshima, Y
    Maruyama, K
    Sekikawa, T
    Ogura, T
    Makino, H
    Sugaya, T
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2588 - A2588
  • [8] Angiotensin II type 1A receptor-deficient mice are protected against proteinuria and development of glomerulosclerosis in remnant kidney model.
    Kashihara, N
    Sugiyama, H
    Okamoto, K
    Kanao, K
    Maeshima, Y
    Maruyama, K
    Satoh, M
    Sekikawa, T
    Makino, H
    Sugaya, T
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3050 - A3050
  • [9] Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase
    Zimnol, Anna
    Amann, Kerstin
    Mandel, Philipp
    Hartmann, Christina
    Schupp, Nicole
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 313 (06) : F1264 - F1273
  • [10] ANALYSIS OF THE RAT TYPE 1A ANGIOTENSIN-II RECEPTOR PROMOTER
    BEASON, KB
    ELTON, TS
    FASEB JOURNAL, 1995, 9 (03): : A294 - A294